These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
275 related items for PubMed ID: 9821435
41. Incidence and risk factors of post-phototherapy neonatal rebound hyperbilirubinemia. Elhawary IM, Abdel Ghany EAG, Aboelhamed WA, Ibrahim SGE. World J Pediatr; 2018 Aug; 14(4):350-356. PubMed ID: 29464578 [Abstract] [Full Text] [Related]
42. Accuracy of transcutaneous bilirubin on covered skin in preterm and term newborns receiving phototherapy using a JM-105 bilirubinometer. Costa-Posada U, Concheiro-Guisán A, Táboas-Ledo MF, González-Colmenero E, González-Durán ML, Suarez-Albo M, Duran Fernández-Feijoo C, Pumarada-Prieto M, Martínez-Reglero C, Fernández-Lorenzo JR. J Perinatol; 2020 Feb; 40(2):226-231. PubMed ID: 31767979 [Abstract] [Full Text] [Related]
43. Accuracy of Transcutaneous Bilirubin Versus Serum Bilirubin Measurement in Preterm Infants Receiving Phototherapy: A Systematic Review. Hynes S, Moore Z, Patton D, O'Connor T, Nugent L. Adv Neonatal Care; 2020 Dec; 20(6):E118-E126. PubMed ID: 32366804 [Abstract] [Full Text] [Related]
47. [Photoprevention or phototherapy in newborn infants born prematurely?]. Romagnoli C, Muzii U, Maggio L, De Carolis MP, Zecca E, Zuppa AA, Tortorolo G. Pediatr Med Chir; 1987 Dec; 9(2):191-5. PubMed ID: 3658802 [Abstract] [Full Text] [Related]
51. Comparison of the effectiveness of phototherapy and exchange transfusion in the management of nonhemolytic neonatal hyperbilirubinemia. Tan KL. J Pediatr; 1975 Oct; 87(4):609-12. PubMed ID: 1159592 [Abstract] [Full Text] [Related]
52. Effect of Phototherapy on the Reliability of Transcutaneous Bilirubin Devices in Term and Near-Term Infants: A Systematic Review and Meta-Analysis. Nagar G, Vandermeer B, Campbell S, Kumar M. Neonatology; 2016 Oct; 109(3):203-12. PubMed ID: 26789390 [Abstract] [Full Text] [Related]
55. Infants with bilirubin levels of 30 mg/dL or more in a large managed care organization. Newman TB, Liljestrand P, Escobar GJ. Pediatrics; 2003 Jun; 111(6 Pt 1):1303-11. PubMed ID: 12777545 [Abstract] [Full Text] [Related]